Debunking common PR myths
I’m sure many PR professionals will agree; public relations is one of the most misunderstood of industries. When I ask friends and family if they know what I do, I’m usually me
Influencers unite to discuss MWC19 Barcelona
[vc_row][vc_column width=”2/3″][vc_column_text]Most people associate this time of year with autumn leaves and darker nights. However, for mobile sector specialists like
What’s going on with cryptocurrency?
Having previously led some successful fintech PR campaigns for a number of clients, here at Babel we aim to keep abreast of news and trends in the sector. One of these we can’t h
Tackling the cyber security problem
You hear it on the news almost daily: a well-known company has been breached, often on a catastrophic scale. Cyber security has become one of the most urgent issues facing modern b
60 Seconds with Babel PR’s Ian Hood
Last week, Babel’s CEO and co-founder, Ian, spoke to Cision Gorkana about his years of experience in the PR industry, the rise of alternative media, and the importance of cre
FAKEBOOK: HOW VIDEO MANIPULATION TECH COULD REVIVE FAKE NEWS
“YOU ARE FAKE NEWS!” “Zero credibility, it’s all fake news.” “The news is fake because so much of the news is fake”. Sound familiar? These are the words of the infamo
A degree of public relations: choosing your University course
It is September and the start of a new academic year. For those who finished their A-levels, there were some fairly sizeable decisions to make. University? Gap year? Career path? A
Schmoozing in PR, and why it is good for PR professionals
When I told people that I was going into PR, aside from their complete and utter lack of knowledge as to what PR is and what exactly PR agencies do (which even now remains a debate
The value of video
Hi, I’m Troy McClure. You may remember me from such Babel blogs as ‘Krusty the Clown’s greatest PR missteps’… Okay, so that’s not a real Babel blog, but chances a
Can mankind live forever?
“Clearly, it is possible, through technology, to make death optional”. These are the words of Martine Rothblatt, founder of biotech firm United Therapeutics. This opinion is ec